Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ferrari IC"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Multicenter study of the natural history and therapeutic responses of patients with chikungunya, focusing on acute and chronic musculoskeletal manifestations - a study protocol from the clinical and applied research in Chikungunya (REPLICK network).
Autorzy:
da Silva Duarte G; Laboratório de Pesquisa Clínica Em Doenças Febris Agudas, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Jones AD; University of California, Berkeley, USA.
de Goes Cavalcanti LP; Universidade Federal Do Ceará, Fortaleza, Brazil.
de Melo Rêgo MJB; Departamento de Bioquímica, Universidade Federal de Pernambuco, Recife, Brazil.
Ribeiro GS; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Boyton RJ; Imperial College of London, London, UK.
Pereira DB; Centro de Pesquisa Em Medicina Tropical de Rondônia, Porto Velho, Brazil.
Croda JHR; Fundação Oswaldo Cruz, Mato Grosso Do Sul, Campo Grande, Brazil.
Costa FTM; Universidade Estadual de Campinas, Campinas, Brazil.
Duarte AP; Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil.
Consolaro MEL; Departamento de Análises Clínicas E Biomedicina, Universidade Estadual de Maringá, Maringá, Brazil.
Stabeli RG; Plataforma de Medicina Translacional, Fundação Oswaldo Cruz, São Paulo, Brazil.
Negrão FJ; Universidade Federal da Grande Dourados, Dourados, Brazil.
Proenca-Modena JL; Universidade Estadual de Campinas, Campinas, Brazil.
Villalobos-Salcedo JM; Fundação Oswaldo Cruz, São Paulo, Brazil.
da Rocha Castelar Pinheiro G; Universidade Estadual Do Rio de Janeiro, Rio de Janeiro, Brazil.
de Barros Albuquerque AP; Departamento de Bioquímica, Universidade Federal de Pernambuco, Recife, Brazil.
de Almeida Barreto FK; Universidade Federal Do Ceará, Fortaleza, Brazil.
Moreira J; Laboratório de Pesquisa Clínica Em Doenças Febris Agudas, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Ferrari IC; Universidade Federal da Grande Dourados, Dourados, Brazil.
Évora PM; Plataforma de Medicina Translacional, Fundação Oswaldo Cruz, São Paulo, Brazil.
da Silva VRS; Departamento de Análises Clínicas E Biomedicina, Universidade Estadual de Maringá, Maringá, Brazil.
Lacerda MVG; Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.
Altmann DM; Imperial College of London, London, UK.
Siqueira AM; Laboratório de Pesquisa Clínica Em Doenças Febris Agudas, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. .
Pokaż więcej
Corporate Authors:
REPLICK network
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Jul 28; Vol. 23 (1), pp. 499. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article
MeSH Terms:
Chikungunya Fever*/diagnosis
Chikungunya Fever*/epidemiology
Chikungunya Fever*/therapy
Humans ; Cohort Studies ; Prospective Studies ; Quality of Life ; Chronic Disease ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł:
Serum biomarkers associated with SARS-CoV-2 severity.
Autorzy:
de Morais Batista F; School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
Puga MAM; School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
da Silva PV; School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
Oliveira R; Associated Prof. Nursing Course., State University of Mato Grosso do Sul, Dourados, MS, Brazil.
Dos Santos PCP; School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
da Silva BO; Laboratory of Research in Health Science, Faculty of Health Science, Federal University of Grande Dourados, Dourados, Brazil.
Tatara MB; Laboratory of Research in Health Science, Faculty of Health Science, Federal University of Grande Dourados, Dourados, Brazil.
Tsuha DH; State Health Department of Mato Grosso do Sul, Center for Strategic Information in Health Surveillance, Campo Grande, Brazil.
Dos Santos Pires MA; Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.; Universitary Hospital of Federal University of Grande Dourados, Federal University of Grande Dourados, Dourados, Brazil.
Gonçalves CCM; School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
Pessoa E Silva R; Federal University of Pernambuco - UFPE, Recife, Brazil.
Ferreira NT; Federal University of Pernambuco - UFPE, Recife, Brazil.
de Barros Albuquerque AP; Federal University of Pernambuco - UFPE, Recife, Brazil.
da Silva Duarte G; Laboratory in Clinical Research of Acute Febrile Illnesses, National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Consolaro MEL; Postgraduate Program in Biosciences and Pathophysiology, State University of Maringá, Maringá, PR, Brazil.; Regional University Hospital of Maringá, State University of Maringá, Maringá, Brazil.
Negrão FJ; Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.; Universitary Hospital of Federal University of Grande Dourados, Federal University of Grande Dourados, Dourados, Brazil.
Ferrari IC; Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
de Goes Cavalcanti LP; Postgraduate Program in Public Health, Federal University of Ceará, Fortaleza, Brazil.; School of Medicine, Christus University Center, Fortaleza, Brazil.; Postgraduate Program in Pathology, Federal University of Ceará, Fortaleza, Brazil.
Trinta KS; Laboratory of Diagnostic Technology, Bio-Manguinhos, Fiocruz, Rio de Janeiro, Brazil.
Ribeiro GS; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; School of Medicine, Federal University of Bahia, Salvador, Brazil.
de Melo Rêgo MJB; Federal University of Pernambuco - UFPE, Recife, Brazil.
Boyton RJ; Department of Infectious Disease, Imperial College London, London, UK.; Lung Division, Royal Brompton and Harefield Hospitals, London, UK.
Siqueira AM; National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Altmann DM; Department of Immunology and Inflammation, Imperial College London, London, UK.
Croda J; School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil. .; Fiocruz Mato Grosso do Sul, Oswaldo Cruz Foundation, Campo Grande, Brazil. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Sep 26; Vol. 12 (1), pp. 15999. Date of Electronic Publication: 2022 Sep 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
SARS-CoV-2*
Biomarkers ; Chemokines ; Cytokines ; Growth Differentiation Factor 15 ; Humans ; Myoglobin ; P-Selectin
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies